HMGA2 and Smads Co-regulate SNAIL1 Expression During Induction of Epithelial-to-mesenchymal Transition

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2008 Oct 4

PMID 18832382

Citations 191

Authors

Sylvie Thuault

E-Jean Tan

Hector Peinado

Amparo Cano

Carl-Henrik Heldin

Aristidis Moustakas

Affiliations

Soon will be listed here.

Abstract

Epithelial-mesenchymal transition (EMT) is important during embryonic cell layer movement and tumor cell invasiveness. EMT converts adherent epithelial cells to motile mesenchymal cells, favoring metastasis in the context of cancer progression. Transforming growth factor-beta (TGF-beta) triggers EMT via intracellular Smad transducers and other signaling proteins. We previously reported that the high mobility group A2 (HMGA2) gene is required for TGF-beta to elicit EMT in mammary epithelial cells. In the present study we investigated the molecular mechanisms by which HMGA2 induces EMT. We found that HMGA2 regulates expression of many important repressors of E-cadherin. Among these, we analyzed in detail the zinc-finger transcription factor SNAIL1, which plays key roles in tumor progression and EMT. We demonstrate that HMGA2 directly binds to the SNAIL1 promoter and acts as a transcriptional regulator of SNAIL1 expression. Furthermore, we observed that HMGA2 cooperates with the TGF-beta/Smad pathway in regulating SNAIL1 gene expression. The mechanism behind this cooperation involves physical interaction between these factors, leading to an increased binding of Smads to the SNAIL1 promoter. SNAIL1 seems to play the role of a master effector downstream of HMGA2 for induction of EMT, as SNAIL1 knock-down partially reverts HMGA2-induced loss of epithelial differentiation. The data propose that HMGA2 acts in a gene-specific manner to orchestrate the transcriptional network necessary for the EMT program.

Citing Articles

Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.

Sravani A, Thomas J Heliyon. 2025; 11(3):e41964.

PMID: 39959483 PMC: 11830326. DOI: 10.1016/j.heliyon.2025.e41964.

Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2.

Bustamante A, Baritaki S, Zaravinos A, Bonavida B Cancers (Basel). 2024; 16(18).

PMID: 39335152 PMC: 11430682. DOI: 10.3390/cancers16183180.

Decoding high mobility group A2 protein expression regulation and implications in human cancers.

Khazem F, Zetoune A Discov Oncol. 2024; 15(1):322.

PMID: 39085703 PMC: 11291832. DOI: 10.1007/s12672-024-01202-x.

Association of deletion polymorphism rs10573247 in the HMGA2 gene with the risk of breast cancer: bioinformatic and experimental analyses.

Najibi K, Moghanibashi M, Naeimi S World J Surg Oncol. 2024; 22(1):142.

PMID: 38802807 PMC: 11131319. DOI: 10.1186/s12957-024-03415-4.

The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer.

Zhao Y, Hu X, Yu H, Sun H, Zhang L, Shao C Research (Wash D C). 2024; 7:0313.

PMID: 38384328 PMC: 10879844. DOI: 10.34133/research.0313.

References

Noro B, Licheri B, Sgarra R, Rustighi A, Tessari M, Chau K . Molecular dissection of the architectural transcription factor HMGA2. Biochemistry. 2003; 42(15):4569-77. DOI: 10.1021/bi026605k. View

Ross S, Hill C . How the Smads regulate transcription. Int J Biochem Cell Biol. 2007; 40(3):383-408. DOI: 10.1016/j.biocel.2007.09.006. View

Moren A, Hellman U, Inada Y, Imamura T, Heldin C, Moustakas A . Differential ubiquitination defines the functional status of the tumor suppressor Smad4. J Biol Chem. 2003; 278(35):33571-82. DOI: 10.1074/jbc.M300159200. View

Kowanetz M, Valcourt U, Bergstrom R, Heldin C, Moustakas A . Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol. 2004; 24(10):4241-54. PMC: 400464. DOI: 10.1128/MCB.24.10.4241-4254.2004. View

Yang J, Mani S, Liu Donaher J, Ramaswamy S, Itzykson R, Come C . Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117(7):927-39. DOI: 10.1016/j.cell.2004.06.006. View

Peinado H, Portillo F, Cano A . Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004; 48(5-6):365-75. DOI: 10.1387/ijdb.041794hp. View

Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, Suzuki H . A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ. 2004; 11(10):1092-101. DOI: 10.1038/sj.cdd.4401467. View

Cui W, Fowlis D, Bryson S, Duffie E, Ireland H, Balmain A . TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell. 1996; 86(4):531-42. DOI: 10.1016/s0092-8674(00)80127-0. View

Valcourt U, Kowanetz M, Niimi H, Heldin C, Moustakas A . TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell. 2005; 16(4):1987-2002. PMC: 1073677. DOI: 10.1091/mbc.e04-08-0658. View

10.

Moustakas A, Heldin C . Non-Smad TGF-beta signals. J Cell Sci. 2005; 118(Pt 16):3573-84. DOI: 10.1242/jcs.02554. View

11.

Zavadil J, Bottinger E . TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24(37):5764-74. DOI: 10.1038/sj.onc.1208927. View

12.

Thiery J, Sleeman J . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7(2):131-42. DOI: 10.1038/nrm1835. View

13.

Massague J, Gomis R . The logic of TGFbeta signaling. FEBS Lett. 2006; 580(12):2811-20. DOI: 10.1016/j.febslet.2006.04.033. View

14.

Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin C, Moustakas A . Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol. 2006; 174(2):175-83. PMC: 2064178. DOI: 10.1083/jcb.200512110. View

15.

Pardali K, Moustakas A . Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta. 2006; 1775(1):21-62. DOI: 10.1016/j.bbcan.2006.06.004. View

16.

Cho H, Baek K, Saika S, Jeong M, Yoo J . Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun. 2006; 353(2):337-43. DOI: 10.1016/j.bbrc.2006.12.035. View

17.

Olmeda D, Jorda M, Peinado H, Fabra A, Cano A . Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene. 2006; 26(13):1862-74. DOI: 10.1038/sj.onc.1209997. View

18.

Cattaruzzi G, Altamura S, Tessari M, Rustighi A, Giancotti V, Pucillo C . The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and function. Nucleic Acids Res. 2007; 35(6):1751-60. PMC: 1874589. DOI: 10.1093/nar/gkl1106. View

19.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

20.

Moustakas A, Heldin C . Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007; 98(10):1512-20. PMC: 11158989. DOI: 10.1111/j.1349-7006.2007.00550.x. View